Staff Reports
Health and Human Services Secretary Robert F. Kennedy, Jr. has kicked off a new information‑gathering push into electromagnetic fields and radiofrequency radiation. The department published a formal Request for Information (RFI) on the Federal Register and opened a public docket on regulations.gov to collect scientific studies, exposure data, clinical observations, and public comments. This is not a rule change — it is a fact‑finding move meant to map what we know and what we don’t about RF/EMF exposures.
What the HHS RFI actually asks
The RFI asks wide, practical questions about real‑world RF exposure from cell phones, Wi‑Fi, smart meters, wearable tech, wireless medical devices, 5G and even emerging 6G systems. HHS wants evidence on health effects (including below current federal limits), how exposures are measured, cumulative exposure over time, and how vulnerable groups like children, pregnant people, and workers might be affected. The department says this effort flows from the MAHA strategy and aims to identify research gaps and prioritize federal study. In plain language: bring your papers, your datasets, and your clinic notes if you want to be heard.
How this fits with the FCC and the science
Don’t pretend the RFI exists in a vacuum. The FCC is already revisiting parts of its RF rules after a D.C. Circuit remand, and courts, regulators, industry, researchers, and advocacy groups will all be watching. An RFI is an information‑gathering tool, not a sudden ban on phones or 5G towers. That matters. Science on RF/EMF is noisy and mixed. Study methods vary. Some papers show signals, others show nothing. HHS is asking for the evidence that can survive real scrutiny — and it should be judged that way, not by anecdotes or alarmist headlines.
Good government asks questions. Good science demands clear methods and reproducible results. Conservatives should welcome careful study of environmental risks. At the same time, we must be blunt: Secretary Kennedy is a polarizing figure in health debates, and political theater can easily shape policy if experts don’t insist on rigor. We should be wary of letting fear drive regulation or of using the RFI to pawn off unvetted claims as policy ammunition. If the federal government moves beyond research to regulation, that step must follow gold‑standard science and proper rulemaking, not Twitter outrage or selective evidence.
So here’s the sensible path forward: scientists, clinicians, industry labs, and ordinary Americans with data should submit their best material to the Federal Register docket. Regulators should coordinate with the FCC, NIH, FDA, and CDC to avoid conflicting signals. And everyone — including HHS — should promise to follow the evidence, not the headlines. In short: investigate, but don’t panic. If the goal is healthier Americans and smarter policy, then rigorous study and transparent debate will get us there. If the goal is a new set of scare stories, well, Congress and the courts will have something to talk about — and taxpayers will pay the bill.
